The Washington Post reports that Rand Paul’s wife bought stock in the drugmaker Gilead Sciences, the manufacturer of remdesivir, an anti-viral drug that is being used to treat patients with COVID-19, the disease caused by coronavirus.  The Pauls, however, did not report the purchase for 16 months, more than a year after the 45-day window for members of Congress to report trades under the Stock Act.

If you’re cynical–like me–you might think that Paul’s long-time antipathy toward public health regulations and preventative measures to prevent the spread of the coronavirus just might be because he wants more people to get treated with remdesivir–which is only used when patients’ conditions have progressed due to infection.

Now I’m not saying, for certain, that the Pauls were evilly leveraging Rand Paul’s position as a US Senator to influence millions of American rubes to push them to get infected so he can reap profits.  There’s no evidence of that, but the question needs to be asked. 

And sure, it’s odd that Kelly Paul and her husband didn’t file the paperwork for stock she bought last February, just a couple months before remdesivir got emergency use authorization for use with coronavirus patients.  Oh, a month after Rand Paul became the first member of the US Senate to test positive.  I’m not saying they did it intentionally–but they should answer questions and why aren’t they answering these questions that we all want answers to.